Name: Mendeley Advisor Briefing Q1 2019
Start: 2019-03-15T14:05:00Z
End: 2019-03-15T14:55:08.000Z
Location: BrightTALK
Rating: 4.6

Researcher Connect webinars feature discuss best practices that make the business of being a researcher and university-level educator easier.

Join us for a continuation of Cell Press's recent Perspectives article highlighting trans and nonbinary STEM researchers from around the world. This lively panel discussion will be joined by six of the article's authors and moderated by the Editor-in-Chief of Cell, Dr. John Pham. 

Our panelists will include: 
Gabriela Fleury (they/them), Rainforest Trust
Sofia Kirke Forslund (she/her), MDC, Charité Berlin
Eartha Mae Guthman (she/her & e/er), Princeton University 
Aflah Hanafiah (she/her), Pennsylvania State University College of Medicine 
Danny McSweeney (he/they), University of Massachusetts Amherst 
Adam Armada-Moreira (he/him), Linköping University

Article Link: https://www.cell.com/cell/fulltext/S0092-8674(21)00698-X

Special Thanks to 500 Queer Scientists (https://twitter.com/500queersci) for serving as a resource for Elsevier Pride on this and so many initiatives

The Future of STEM: Perspectives from Early Career Trans & Nonbinary Researchers

In the final part of our Research metrics in action webinar series. Join Sahar Abuelbashar to dive deep into how you can apply metrics in the real world. This is the third webinar in our series focusing on understanding and getting the best from research metrics and indicators. 

In this session, Sahar looks at metrics in real-life use cases, asking:

-	What are wild metrics?
-	How can you apply research intelligence solutions to find the right metrics to support your 
        case?
-	How can metrics support strategic decision making?
-	How can metrics help find partners to support grant applications?
-	How can you see who is citing your work and from where?

Part 3: Understanding how metrics can support real-world decisions

In the second webinar in our series focusing on understanding and getting the best from research metrics and indicators, Lesley shares insights into the expectations of funding bodies.

Lesley discusses how best to use metrics and indicators in your grant application. Among the topics covered are:

-	The research funding cycle 
-	Funder wants, needs and other expectations 
-	The centrality of peer review and how this plays a role
-	What metrics and indicators can support your case

The third session in the series, Understanding how metrics can support real-world decisions is on June 22 at 2 p.m. GMT. Learn more https://www.elsevier.com/events/webinars/SSRN-webinars?aaref=?commid=487988

Part 2: Understanding what funding bodies expect from grant applications

Join Dr. Andrew Plume for a discussion about best practices for research metrics. This is the first part of our webinar series Research Metrics in Action focusing on understanding and getting the best from research metrics and indicators. 

In this session, Andrew takes an in-depth look at the statements made in the Leiden Manifesto and the Declaration on Research Assessment. Questions covered include:

-	Why have these statements recently emerged as a critical topic for discussion? 
-	What do they actually say about best practices for using research metrics in academic 
        settings?
-	How is Elsevier working to align our policies and practices with the Leiden Manifesto and 
        DORA?

The second session in the series, Understanding what funding bodies expect from grant applications is on June 15 at 2 p.m. GMT. Learn more https://www.elsevier.com/events/webinars/SSRN-webinars?aaref=?commid=487986

Part 1: Responsible research metrics and evaluation

Join John McConnell, Editor-in-Chief of The Lancet Infectious Diseases to update yourself on the latest scientific viewpoints regarding the workings of the COVID-19 vaccines. In this professional webinar, John will cover areas such as: 
• Effectiveness of vaccines in preventing disease, including variant viruses 
• Vaccine safety – reactogenicity, anaphylaxis, clotting disorders, Bell’s palsy 
• What vaccines are available and their mechanisms of action 
• The path to making vaccines available worldwide 
• How has the pandemic affected the research landscape 
Moreover, you will get the opportunity to secure answers to your own pressing questions. You won’t want to miss this valuable webinar.

About the presenter: 
John McConnell studied clinical microbiology and parasitology at the University of East London, before spending 6 years researching septic-shock-related topics at the Royal Postgraduate Medical School, Hammersmith Hospital, London (now part of Imperial College London). He joined The Lancet in 1990 as a peer-review editor before becoming the first Web Editor in 1996. In 2001, John was the founding editor of The Lancet Infectious Diseases. He has appeared as an expert commentator on BBC, ITV, Channel 4, Sky News, Al Jazeera, CNBC, CNN, and CCTV America. In the past year, The Lancet Infectious Diseases has published some of the most impactful research on COVID-19.

COVID-19 Vaccines: An Update on Research & Global Availability

Research assessment should not be centered solely on bibliometrics such as publication and citation metrics but should encompass other measures that address the broad range of assessment-related questions. These cover research inputs, outputs and outcomes, such as funding, collaboration, usage, commercialization and the adoption of innovation. As more diverse data sources and metrics are used, a richer and more informative picture of research emerges.

The International Center for the Study of Research (ICSR) was established by Elsevier in 2019 with a mission to further the study of research and thus to contribute to the evidence base supporting the practice of research strategy, evaluation and policy. In 2020, ICSR and Elsevier signed the Declaration on Research Assessment (DORA) and endorsed the Leiden Manifesto for Research Metrics, two internationally-recognized statements of best practice in responsible research assessment.

In this Library Connect webinar, Christopher Belter will discuss what responsible research assessment might look like in practice for a large biomedical funding agency. ICSR staff members Andrew Plume and Holly Falk-Krzesinski will then discuss the recommendations of both DORA and the Leiden Manifesto and their implications for Elsevier as well as for librarians and their users.

Introduction:    
M.J. Tooey, Associate Vice President, Academic Affairs and Executive Director, Health Sciences and Human Services Library, University of Maryland, Baltimore
Presenters:         
Christopher Belter, Program Analyst, Eunice Kennedy Shriver NICHD Development                             
Holly Falk-Krzesinski, Vice President, Research Intelligence, Elsevier
Andrew Plume, President, International Center for the Study of Research; and Senior Director of Research Evaluation, Elsevier

Advancing responsible research assessment: implications for librarians

Note there are two sessions of this webinar to support multiple time zones, an AM and PM. This is the PM session.

Hello Advisors!
Join the Mendeley Team for an exclusive, one-hour live discussion about program updates designed to help bring your research to life.

This Advisor-only webinar will cover new program features that are helping us create a better Advisor community, improved Mendeley tool releases, and will include a generous amount of time for questions and answers with the team, so please feel comfortable to participate.

Speak to you soon!
The Mendeley Team

Agenda:
-Welcome message
-Advisor program overview
-Mendeley Cite notes
-Mendeley Reference Manager 
-Q&A

Mendeley Advisor quarterly briefing PM session

Note there are two sessions of this webinar to support multiple time zones, an AM and PM. This is the AM session.

Hello Advisors!
Join the Mendeley Team for an exclusive, one-hour live discussion about program updates designed to help bring your research to life.

This Advisor-only webinar will cover new program features that are helping us create a better Advisor community, improved Mendeley tool releases, and will include a generous amount of time for questions and answers with the team, so please feel comfortable to participate.

Speak to you soon!
The Mendeley Team

Agenda:
-Welcome message
-Advisor program overview
-Mendeley Cite notes
-Mendeley Reference Manager 
-Q&A

Mendeley Advisor quarterly briefing AM session

Join this interactive webinar session with Bonnie Ky, MD, MSCE, FACC, Editor-in-Chief of JACC: CardioOncology to learn strategies on how to develop a clinical research career, with examples of how to successfully ask and answer research questions in cardio-oncology. You can expect to learn about the following:
- Important components of building a successful research career from scientific questions to team building
- Grant submission
- Overview of the publication process
- Key challenges faced by every clinical researcher and how to tackle them to build a successful career

Sign up for this engaging session with Dr. Bonnie Ky today and get an opportunity to find answers to your pressing questions during the Q&A session of the webinar.

About Bonnie Ky, MD, MSCE, FACC:
Dr. Bonnie Ky is the Founders Associate Professor of Medicine and Epidemiology and tenured physician-scientist at the University of Pennsylvania and serves as the Director for the Penn Center for Quantitative Echocardiography and is the founding Director of the Penn Cardio-Oncology Translational Center of Excellence. She leads a highly active NIH-funded translational research program in cardio-oncology and is the PI of multiple investigator-initiated cohort studies and clinical trials focused on the study of the cardiotoxic effects of doxorubicin, trastuzumab, sunitinib, and radiation therapy in breast, renal cell, and lung cancers, and lymphoma patients.

How to Develop a Multi-disciplinary Clinical Research Career

Learn all about innovation, growth in the multi-disciplinary content and the expanding open access publishing strategy at Cell Press with Dr. Deborah Sweet, Senior Vice President of Publishing at Cell Press. 

You can expect to learn more about the community outreach programs at Cell Press like webinars, symposia, Cell Mentor, Sneak Peek, STAR Methods, STAR Protocols and much more which can help your researchers as well as institutes to grow faster and deliver a higher impact in the world. 

We promise to make the webinar engaging and to answer all your questions around Cell Press. At Cell Press, everything we do aims to drive research forward — whether it's working with authors, enhancing the peer review process, or developing innovations in publishing. We put science first, science that people talk about. 

Join Dr. Sweet in this engaging webinar and make sure to bring along your colleague and friends who may benefit from these helpful resources.

Innovation at Cell Press: Make the most of free Cell Press resources

Learn techniques and strategies for publishing strategies to give you the best chance of successfully publishing in highly selective journals with Dr. Robert D. Eagling, editor-in-chief of Chem (a Cell Press journal). Dr. Eagling will share tips on developing your papers for premium publications (with special focus on researchers based in the Eastern Europe region), elaborate on his experience of working with researchers and authors throughout the research publishing cycle and discuss the opportunity to broadly disseminate findings. Dr. Eagling will also share more details about the growth of Cell Press journals in the physical sciences field. Such details will include the launch of many new titles, such as Chem, Matter, Joule, and One Earth. He’ll also outline Cell Press’s approach to high-demand, multi-disciplinary content and expanding OA publishing strategies at Cell Press. Join this engaging webinar and ask any remaining questions in the Q&A session. Don’t forget to extend this invitation to your colleagues who might find this of interest.

About Robert Eagling: 
Robert Eagling, Ph.D., is a graduate of Newcastle University in England and brings to Chem around 15 years of experience in chemistry publishing. He came to Cell Press from the Royal Society for Chemistry (RSC), where he helped grow submissions and readership of Chemical Communications, increased the visibility and impact of Chemical Society Reviews in 10 years from 13 to 34, and led the launch of Chemical Science, the RSC’s flagship general chemistry journal with Professor David McMillan as the inaugural Editorial Board Chairman.

Best Practices in Submitting Research for Highly Selective Journals

Cancer is one of the leading causes of mortality worldwide, and an increasing threat in low-income and middle-income countries. In 2013 and 2015, The Lancet Oncology published two Commissions that highlighted the cancer landscape in Latin America and how it differed from more developed countries. The reports showed that funding for health care was just a small percentage of national gross domestic product and the percentage of health-care funds diverted to cancer care was even lower. Funding, insurance coverage, numbers of doctors, health-care workers, resources, and equipment were inequitably distributed between and within Latin American countries. The Commissions emphasised the need for structural reforms in health-care systems, the need for dedicated cancer control programmes for disenfranchised populations, the importance of expanding coverage of cancer registries and cancer plans, and the effect of implementing policies to improve primary cancer prevention. In this webinar, renowned experts from Brazil, Argentina, and Spain, revisit cancer control in Latin America via a more contemporaneous lens, with a focus on the challenges surrounding academic research funding, clinical trial recruitment, big data, and wider access to the latest diagnostic technologies.

Emerging technologies and clinical research in Latin America

Cancer kills more than 100,000 children each year, and yet 80% of pediatric cancers are curable with currently available interventions. Notably, the majority of these deaths occur in low‐income and middle-income countries. Yet no reliable data are available in low-income and middle-income countries on the burden of childhood cancer; on the cost of effective interventions; on current health coverage levels; or on the cost, feasibility, or health and economic benefits of scaling-up effective coverage.

In March, 2020, The Lancet Oncology published a Commission on Sustainable care for children with cancer, which provided a new analysis of the global childhood cancer burden and developed an economic investment case and evidence-based medical framework for implementing, integrating, and scaling up care pathways for childhood cancer.

Join Dr. Ali Landman, Deputy Editor of The Lancet Oncology, and Commission authors, as they discuss the aims, findings, and recommendations from the Commission.

Sustainable care for children with cancer: a Lancet Oncology Commission

In this 60 minute training led by Elsevier staff, you will learn everything you need to know to get started using Elsa. This webinar is primarily suited for new Elsa users, but Elsa users of all levels are welcome to join to learn more about Elsa.

Elsa Training: How to Get Started in Elsa

Gender equity is not only a matter of justice and rights, it is crucial for producing the best research and providing the best care to patients. If the fields of science, medicine, and global health are to improve human lives, they must be representative of the societies they serve. The fight for gender equity is everyone’s responsibility: men and women, researchers, clinicians, funders, institutional leaders, and, yes, even medical journals. 

Join Dr Lan-Lan Smith, Editor-in-Chief of The Lancet Haematology, to learn about:
• Why is gender equity important in research 
• What do statistics say about diversity and inclusion in publishing
• What initiatives have been started at The Lancet to bridge the gap

Improving diversity and inclusion in research and publishing

Finding the right journal to publish your research and structuring your research to publish in high impact journals can be a challenge. Learn techniques and strategies to publish in high impact journals like the Journal of Thoracic Oncology with Dr. Alex Adjei, Editor-in-Chief.

You can expect to learn about:
-Manuscript preparation tips
-Features of successful manuscripts
-Fatal errors in manuscripts that lead to outright rejection
-The editorial process
-How to publish in JTO and its new spin-off JTO Clinical Research Reports
-New initiatives at the Journal

About Dr. Alex Adjei:
Alex A. Adjei is a Professor of Oncology and Professor of Pharmacology in the Mayo College of Medicine. He is also a consultant in Medical Oncology at Mayo Clinic. Dr. Adjei is Director of the Early Cancer Therapeutics Program across all three Mayo Clinic sites, and leader of the Lung Cancer Program across all 3 Mayo Clinic sites. He is the Principal Investigator of the Mayo Phase I and Phase II NCI grants. Dr Adjei has served on a number of National Cancer Institute (US) Committees. He is currently co-chair of the Thoracic Malignancies Steering Committee. Dr Adjei is a past member of the IASLC Board of Directors.  He is the Editor-in-Chief of the Journal of Thoracic Oncology and the inaugural Editor-in-Chief of JTO Clinical and Research Reports. Dr. Adjei’s research is focused on experimental therapeutics and clinical drug development. He received the first ASCO Drug Development Research Professorship 2012-2017, in recognition of his mentorship and his work in cancer drug development. He has authored 280 publications dealing primarily with preclinical pharmacology and phase I trials as well as novel therapeutics/phase II trials of lung cancer.

How to publish with the Journal of Thoracic Oncology

Librarians are powerful advocates for informing and engaging their researchers in the open science landscape. In this webinar, Elsevier product managers will present collaborative tools that enable your researchers to discover data, share scholarly insights, and improve their research outcomes.

•Open data sets that support research collaboration across disciplines
•Enhancing user experience for open access across research products 
•Driving the future of open science through partnerships 
•Building global visibility and impact with Diamond OA journals and OERs
•Open access options for sharing early stage research and preprints 

Presenters:

Promita Chatterji, Product Manager, Digital Commons Journals
Shirley Decker-Lucke, Content Director, SSRN
Wouter Haak, VP Research Data Management, Elsevier
Sebastien Schlosser, Director of Strategic Business Development, Elsevier
Steve Watson, Director of Product Management, Elsevier

Open science tools for discovering, promoting and sharing research

Pursuing a career as a physician-scientist can be daunting, especially as the success rates for securing research grants has declined from 33% to 19%, while the number of grant applications has increased by 72%. However, the pathway can provide personal and professional fulfillment and dynamism, if the individual is equipped with a roadmap for success. Valentin Fuster, MD, PhD, MACC, editor in chief of the Journal of the American College of Cardiology (JACC), and Harlan M. Krumholz, MD, SM, FACC, director of the Yale Center for Outcomes Research and Evaluation at Yale School of Medicine, will discuss how to maintain a successful physician-scientist career at three stages: early career, mid-career and senior. They will include tips for grant receipts, the importance of the mentee/mentorship relationship, and the need for creativity in grant submissions. In addition, viewers will have the opportunity to ask these thought leaders questions and pointers. 

About the presenters:
Dr. Valentin Fuster serves The Mount Sinai Hospital as Physician-in-Chief, as well as Director of Mount Sinai Heart, the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health. He is also the Richard Gorlin, MD/Heart Research Foundation Professor, Icahn School of Medicine at Mount Sinai.
 
Dr. Harlan Krumholz is a cardiologist and health care researcher at Yale University and Yale New Haven Hospital. He also serves as Director of the Yale Center for Outcomes Research and Evaluation (CORE) at Yale School of Medicine.

Learn more about the JACC family of journals at JACC.org.

How to Become a Successful Researcher At Every Stage of Your Career

In this session, we give updates on Support,  Mendeley Data, Mendeley Cite and Notebook.

Mendeley Advisor Briefing Q1 2019

Mendeley

The medical research community on BrightTALK brings together medical and research professionals. Find relevant webinars on medical research, laboratory science, continuing medical education and more presented by recognized medical researchers. Join the conversation by participating in live webinars and round table discussions on the latest in medical devices, medical research practices and trends in the healthcare industry.

Medical Research

Join the BrightTALK forensic science community for access to online forensics training from respected professionals in the field. Study forensic science online to learn necessary skills for trace evidence in forensics, liquid and gas chromatography and sample preparation. You can also attend live webinars to interact with forensic scientists and have your questions answered.

Forensic Science

Get powerful life science insights from influential experts. Connect with thought leaders and colleagues to get the most up-to-date knowledge on strategies and initiatives to accelerate the transformation of U.S. and global health care from a volume- to value-based marketplace.

Life Sciences

The research and development community on BrightTALK brings together leading professionals in healthcare, technology and manufacturing to present on current topics in their fields. From big data in healthcare to online forensics training and medical research practices, the community is an exceptional resource for those looking to expand their knowledge. Be part of the conversation by joining the community and participating in interactive live webinars.

Mendeley Advisor Briefing Q1 2019

Presented by

About this talk

More from this channel